CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Novartis AG Company Snapshot
Novartis AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novartis with three other pharmaceutical manufacturers in Europe: Roche Holding Aktiengesellschaft (2016 sales of 50.58 billion Swiss Francs [US$52.52 billion] of which 77% was Pharmaceuticals), Sanofi S.A. of France (34.71 billion Euro [US$39.85 billion] of which 84% was Pharmaceuticals), and Bayer AG which is based in Germany (46.77 billion Euro [US$53.70 billion] of which 35% was Pharmaceuticals & Biological Products).

Sales Analysis. Novartis reported sales of 48.88 billion Swiss Francs (US$50.75 billion) for the year ending December of 2016. This represents a very small increase of 0.7% versus 2015, when the company's sales were 48.55 billion Swiss Francs. Despite this increase, sales are still slightly below the level achieved in 2014, when Novartis reported sales of 48.98 billion Swiss Francs. The sales level in 2016 was fairly close to the level five years ago: in 2011, Novartis had sales of 51.57 billion Swiss Francs. Sales of Sandoz saw an increase that was more than double the company's growth rate: sales were up 13.6% in 2016, from 8.83 billion Swiss Francs to 10.03 billion Swiss Francs. Novartis also saw significant increases in sales in Innovative Medicines (up 9.7% to 32.19 billion Swiss Francs) . Not all segments of Novartis experienced an increase in sales in 2016: sales of Alcon fell 39.3% to 5.75 billion Swiss Francs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Novartis AG
  Stock Performance Chart for Novartis AG
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 79.90
(Figures in Swiss Francs)
1 Week 1.1%   13 Weeks 2.3%  
4 Weeks 8.1%   52 Weeks -0.6%  
 
Novartis AG Key Data:
  Ticker: NOVN Country: Switzerland
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 48,876,384,480
(Year Ending Jan 2017).
Employees: 118,393
  Currency: Swiss Francs Market Cap: 187,196,929,457
  Fiscal Yr Ends: December Shares Outstanding: 2,342,890,231
  Share Type: Namenaktie Closely Held Shares: 157,942,587
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.